<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2855">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04714138</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A03110-39</org_study_id>
    <nct_id>NCT04714138</nct_id>
  </id_info>
  <brief_title>Remote Video Consultation for Quality of Life Assessment in Patients Hospitalised After COVID-19 Infection</brief_title>
  <acronym>TELECOVID</acronym>
  <official_title>Remote Evaluation of Quality of Life and Functional Capacities in Patients Hospitalised for COVID-19: a Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier du Havre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe Hospitalier du Havre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Around 90.000 patients have been hospitalised due to COVID-19 infection in France between&#xD;
      March 1st and June 15th; 19% of those requiring intensive care. Approximately 80% of these&#xD;
      patients have been discharged home by September 30th. Nonetheless, COVID-19 infection along&#xD;
      with intensive care consequences are very likely to impede those patients quality of life and&#xD;
      functional capacities.&#xD;
&#xD;
      This study aims to describe the quality of life outcomes and functional capacities of&#xD;
      COVID-19 survivors, at least 6 months after primary care hospital discharge.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 5, 2021</start_date>
  <completion_date type="Anticipated">March 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 20, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Health-related quality of life</measure>
    <time_frame>6-months after hospital discharge during remote video consultation</time_frame>
    <description>Measured with the Short-Form health survey (SF-36) scale (score ranging form 0 (worst score) to 100 (best score) per item)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional capacity</measure>
    <time_frame>6-months after hospital discharge during remote video consultation</time_frame>
    <description>One-minute Sit-to-stand test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Independency</measure>
    <time_frame>6-months after hospital discharge during remote video consultation</time_frame>
    <description>KATZ score (ranging 0 (fully dependent) to 6 (fully independent))</description>
  </secondary_outcome>
  <enrollment type="Anticipated">190</enrollment>
  <condition>Covid19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        COVID-19 adults patients hospitalised at Le Havre hospital between March 1st and June 15th&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patient&#xD;
&#xD;
          -  COVID-19 hospitalisation at Le Havre hospital between March 1st and June 15th&#xD;
&#xD;
          -  Non-opposition during first phone contact&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Guardianship&#xD;
&#xD;
          -  Juvenile patients&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Inability to communicate&#xD;
&#xD;
          -  Cognitive disorders&#xD;
&#xD;
          -  Deceased patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Yann Combret, PhD, PT</last_name>
    <phone>+33786952577</phone>
    <email>yann.combret@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Clément Medrinal, PhD, PT</last_name>
    <phone>+33664615110</phone>
    <email>medrinal.clement.mk@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Groupe Hospitalier Du Havre</name>
      <address>
        <city>Montivilliers</city>
        <state>Normandie</state>
        <zip>76290</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yann Combret, PhD, PT</last_name>
      <phone>+33786952577</phone>
      <email>yann.combret@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Yann Combret, PhD, PT</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clément Medrinal, PhD, PT</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guillaume Prieur, PhD, PT Cdt</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin Tonneville, PT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Geoffrey Kerné, PT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Flore Pholoppe, OT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandre Eudes, PT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>January 14, 2021</study_first_submitted>
  <study_first_submitted_qc>January 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 19, 2021</study_first_posted>
  <last_update_submitted>January 22, 2021</last_update_submitted>
  <last_update_submitted_qc>January 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

